MEBUCAÏNE Dolo spray 8.75 mg fl 15 ml

7680690440015 CH-69044 R02AX01 12.03.2.
MEBUCAÏNE Dolo spray 8.75 mg fl 15 ml
MEBUCAÏNE Dolo spray 8.75 mg fl 15 ml
MEBUCAÏNE Dolo spray 8.75 mg fl 15 ml
1 / 3
google

Details

Product number
6904401
CPT
-
Packaging group
15
Unit
ml
Composition
flurbiprofenum 17.16 mg, saccharinum natricum, acidum citricum, natrii hydroxidum, dinatrii phosphas dodecahydricus, betadexum, hydroxypropylbetadexum, aromatica (Kirsch) cum ethanolum et cinnamaldehydum et eugenolum et limonenum et citralum, aqua purificata, ad solutionem pro 1 ml corresp. natrium 1.59 mg.

Articles (1)

Mebucaïne Dolo Spray 8.75 mg, Spray zur Anwendung in der Mundhöhle
Spray zur Anwendung in der Mundhöhle
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/01/2025
Patient information leaflet
Français
22/01/2025
Patient information leaflet
Italien
22/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
17.16 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
1.59 MG Substance HBESI

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69044
Drug name
Mebucaïne Dolo Spray, Spray zur Anwendung in der Mundhöhle
Galenic form
SPRL
ATC Code
R02AX01
Authorization status
Z
Dispensation category
D
First authorization
13/09/2023
Authorization expiration date
12/09/2028
IT number
12.03.2.
Domain
Human medicine
Field of application
Kurzzeitige symptomatische Behandlung schmerzhafter Entzündungen der Rachenschleimhaut

Packaging details

Description (FR)
MEBUCAÏNE Dolo spray 8.75 mg fl 15 ml
Description (DE)
MEBUCAÏNE Dolo Spray 8.75 mg Fl 15 ml
Market launch
13/09/2023
Narcotic (BTM)
No